If telehealth is here to stay, how is the industry adjusting?
Gina Parry
Advertisement
Gina Parry, National Account Manager, VAI
Articles by Gina Parry
There’s no need for companies to turn to fancy technologies in order to meet Drug Supply Chain Security Act compliances by the deadline, writes Gina Parry.
Advertisement
Latest Updated Articles
- Keeping Up with Telehealth: Pharma’s Evolution
December 9th 2020
- DSCSA Deadlines: Is Your Supply Chain Ready?
August 4th 2019
Advertisement
Advertisement
Trending on PharmExec
1
ANI Pharmaceuticals to Acquire Egetis Therapeutics, Egetis Sells Priority Review Voucher for $190 Million
2
Why Leronlimab Isn’t Just Another Repurposed Drug: Q&A with Dr. Jay Lalezari
3
Pharmaceutical Executive Daily: Nxera Licenses EP4 Agonist to AbbVie
4
What Does a Positive Reading for Leronlimab Mean for How the Industry Thinks About Repurposing Old Biologics Into Oncology?
5